The COVID-19 pandemic has led to unprecedented demand on the global healthcare
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …

Spinal cord involvement can be observed in the course of immune-mediated disorders.
Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy …

Background An increasing number of reports on associations between neoplasms and
neuromyelitis optica spectrum disorder (NMOSD) have been published over the past …

Neuromyelitis optica spectrum disorders (NMOSD) are autoimmune, astrocytopathic
diseases affecting the central nervous system (CNS), especially the central optic nerve and …

Isolated paraneoplastic myelopathy (IPM) is a rare neurological manifestation of systemic
cancer and represents an intermediate-risk phenotype of disease according to the …

Paraneoplastic neurological syndrome (PNS) is an uncommon condition that occurs as a
result of the immune system mistakenly attacking the central and peripheral nervous …

Objective: Rare coexistence of disease or pathology Background: Neuromyelitis optica
spectrum disorder (NMOSD) is a demyelinating disease of the central nervous system that …

A 71-year-old Chinese woman, who received the first dose of COVID-19 vaccination on 1
July 2021 and a second dose on 27 July 2021, was admitted to the Department of …

Background: Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a
subtype of stiff-person syndrome, a rare cerebrospinal disease that causes brainstem …

Neuromyelitis optica spectrum disorder (NMOSD), a demyelinating CNS disorder in which
inflammatory cells infiltrate the spinal cord and optic nerve, has been identified as an AQP4 …